A detailed history of Israel Englander (Millennium Management LLC) transactions in Biogen Inc. stock. As of the latest transaction made, Millennium Management LLC holds 29,600 shares of BIIB stock, worth $4.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,600
Previous 239,847 87.66%
Holding current value
$4.41 Million
Previous $55.6 Million 89.68%
% of portfolio
0.0%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $29.9 Million - $37.5 Million
158,289 Added 66.0%
398,136 $77.2 Million
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $12.1 Million - $15 Million
63,435 Added 35.96%
239,847 $55.6 Million
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $36.4 Million - $46 Million
171,877 Added 3790.01%
176,412 $38 Million
Q4 2023

Feb 14, 2024

SELL
$222.59 - $267.94 $8.82 Million - $10.6 Million
-39,639 Reduced 89.73%
4,535 $1.17 Million
Q2 2023

Aug 14, 2023

SELL
$275.25 - $318.06 $129 Million - $149 Million
-469,218 Reduced 91.4%
44,174 $12.6 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $44.8 Million - $51.1 Million
174,807 Added 51.63%
513,392 $143 Million
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $145 Million - $176 Million
-574,120 Reduced 62.9%
338,585 $93.8 Million
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $64.5 Million - $88.9 Million
331,058 Added 56.92%
912,705 $244 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $4.23 Million - $5.03 Million
-22,566 Reduced 3.73%
581,647 $119 Million
Q1 2022

May 16, 2022

BUY
$193.77 - $244.14 $37.1 Million - $46.7 Million
191,325 Added 46.34%
604,213 $127 Million
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $31.6 Million - $40.6 Million
141,069 Added 51.9%
412,888 $99.1 Million
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $9.96 Million - $13 Million
-35,210 Reduced 11.47%
271,819 $76.9 Million
Q2 2021

Aug 16, 2021

BUY
$259.0 - $414.71 $39.4 Million - $63.1 Million
152,271 Added 98.39%
307,029 $106 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $23 Million - $26.9 Million
-94,658 Reduced 37.95%
154,758 $43.3 Million
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $6.63 Million - $9.97 Million
-28,043 Reduced 10.11%
249,416 $61.1 Million
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $47 Million - $54.2 Million
177,339 Added 177.13%
277,459 $78.7 Million
Q2 2020

Aug 14, 2020

BUY
$258.66 - $342.55 $7.19 Million - $9.52 Million
27,785 Added 38.41%
100,120 $26.8 Million
Q1 2020

May 14, 2020

SELL
$268.85 - $341.04 $120 Million - $153 Million
-447,279 Reduced 86.08%
72,335 $22.9 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $29.5 Million - $40.8 Million
-134,114 Reduced 20.52%
519,614 $154 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $38.7 Million - $43.4 Million
178,008 Added 37.42%
653,728 $152 Million
Q2 2019

Aug 15, 2019

SELL
$219.29 - $241.72 $17.2 Million - $19 Million
-78,399 Reduced 14.15%
475,720 $111 Million
Q2 2019

Aug 14, 2019

BUY
$219.29 - $241.72 $97.9 Million - $108 Million
446,361 Added 414.23%
554,119 $113 Million
Q1 2019

May 14, 2019

BUY
$216.71 - $338.96 $6.7 Million - $10.5 Million
30,916 Added 40.23%
107,758 $25.5 Million
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $52.8 Million - $66.9 Million
-189,643 Reduced 71.16%
76,842 $23.1 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $32.7 Million - $42.8 Million
111,438 Added 71.87%
266,485 $94.2 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $74.4 Million - $88.7 Million
-289,001 Reduced 65.08%
155,047 $45 Million
Q1 2018

May 15, 2018

BUY
$260.13 - $367.91 $101 Million - $143 Million
389,965 Added 721.05%
444,048 $122 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $41.1 Million - $46.1 Million
-133,645 Reduced 71.19%
54,083 $17.2 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $52.8 Million - $61.9 Million
187,728
187,728 $58.8 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.